Wall Street Experts

Prognozy kwartalne Lineage Cell Therapeutics, Inc.


Dane w mln

28 11 27 10 9 26 8 25 7 24 23 6 5 22 4 21 3 20 2 19 1 18 17 0
Okres 2024-12-31 2024-12-31 2025-03-31 2025-03-31 2025-06-30 2025-06-30 2025-09-30 2025-09-30 2025-12-31 2025-12-31 2026-03-31 2026-03-31 2026-06-30 2026-06-30 2026-09-30 2026-09-30 2026-12-31 2026-12-31 2027-03-31 2027-03-31 2027-06-30 2027-06-30 2027-09-30 2027-09-30 2027-12-31 2027-12-31 2028-03-31 2028-03-31 2028-06-30 2028-06-30 2028-09-30 2028-09-30 2028-12-31 2028-12-31
Przychód (średnia) 1.62 1.62 1.72 1.72 1.39 1.39 1.80 1.80 1.75 1.75 10.86 10.86 6.64 6.64 3.07 3.07 3.32 3.32 1.20 1.20 1.18 1.18 1.22 1.22 1.29 1.29 4.28 4.28 4.67 4.67 5.09 5.09 5.56 5.56
Przychód Δ kw/kw -70.84% 0.00% 6.10% 6.10% -19.37% -19.37% 30.02% 30.02% -2.92% -2.92% 520.09% 520.09% -38.79% -38.79% -53.86% -53.86% 8.39% 8.39% -63.91% -63.91% -1.82% -1.82% 3.71% 3.71% 5.37% 5.37% 232.52% 232.52% 9.12% 9.12% 9.12% 9.12% 9.12% 9.12%
Przychód (min) 1.24 1.24 1.48 1.48 1.20 1.20 1.56 1.56 1.51 1.51 9.36 9.36 5.73 5.73 2.64 2.64 2.87 2.87 1.03 1.03 1.02 1.02 1.05 1.05 1.11 1.11 3.69 3.69 4.03 4.03 4.39 4.39 4.79 4.79
Przychód (max) 2.00 2.00 2.24 2.24 1.81 1.81 2.35 2.35 2.28 2.28 14.15 14.15 8.66 8.66 4.00 4.00 4.33 4.33 1.56 1.56 1.54 1.54 1.59 1.59 1.68 1.68 5.58 5.58 6.09 6.09 6.64 6.64 7.25 7.25
EBITDA (średnia) -1.62 -1.62 -1.72 -1.72 -1.39 -1.39 -1.80 -1.80 -1.75 -1.75 -10.86 -10.86 -6.64 -6.64 -3.07 -3.07 -3.32 -3.32 -1.20 -1.20 -1.18 -1.18 -1.22 -1.22 -1.29 -1.29 -4.28 -4.28 -4.67 -4.67 -5.09 -5.09 -5.56 -5.56
EBIT (średnia) -1.62 -1.62 -1.72 -1.72 -1.39 -1.39 -1.80 -1.80 -1.75 -1.75 -10.86 -10.86 -6.64 -6.64 -3.07 -3.07 -3.32 -3.32 -1.20 -1.20 -1.18 -1.18 -1.22 -1.22 -1.29 -1.29 -4.28 -4.28 -4.67 -4.67 -5.09 -5.09 -5.56 -5.56
EBIT % -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00% -100.00%
Zysk netto (średni) -5.33 -5.33 -5.81 -5.81 -6.14 -6.14 -5.49 -5.49 -5.81 -5.81 -0.73 -0.73 -3.45 -3.45 -5.70 -5.70 -6.14 -6.14 -5.87 -5.87 -5.76 -5.76 -5.95 -5.95 -7.35 -7.35 -5.72 -5.72 -5.47 -5.47 -5.90 -5.90 -6.53 -6.53
Zysk netto % -328.62% -328.62% -337.95% -337.95% -442.42% -442.42% -304.47% -304.47% -332.05% -332.05% -6.75% -6.75% -51.99% -51.99% -185.96% -185.96% -184.63% -184.63% -489.11% -489.11% -489.54% -489.54% -486.83% -486.83% -570.95% -570.95% -133.67% -133.67% -117.17% -117.17% -115.82% -115.82% -117.53% -117.53%
EPS (średnia)
Liczba analityków (Przychody) 4 4 1 1 7 7 2 2 2 2 3 3 5 5 4 4 4 4 4 4 3 3 3 3 3 3 2 2 5 5 4 4 4 4
Liczba analityków (EPS) 3 3 1 1 6 6 3 3 3 3 4 4 3 3 3 3 4 4 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3
symbol LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX LCTX